VEGF is aberrantly elevated in GBM, causing pathological disruption of the BBB, further allowing leakage of neurotoxic molecules, interfering with tumor microenvironment homeostasis, and contributing to poor patient outcome [21,22,23]. Here, VEGFA is linked to glioblastoma.